Lepu Biopharm
1 known investors
Find your way into Lepu Biopharm
Lepu Biopharma is a Chinese biopharmaceutical company that develops antibody-drug conjugates (ADCs) and other oncology drugs, including the CD20-targeting ADC MRG001 for relapsed/refractory diffuse large B-cell lymphoma. Its candidate drugs undergo clinical trials and regulatory review by China's National Medical Products Administration.
Investors · 1
Frequently asked questions
- What does Lepu Biopharm do?
- Lepu Biopharma is a Chinese biopharmaceutical company that develops antibody-drug conjugates (ADCs) and other oncology drugs, including the CD20-targeting ADC MRG001 for relapsed/refractory diffuse large B-cell lymphoma. Its candidate drugs undergo clinical trials and regulatory review by China's National Medical Products Administration.
- Who are Lepu Biopharm's investors?
- Lepu Biopharm's investors include Vivo Capital.